IN2013MU03311A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03311A
IN2013MU03311A IN3311MU2013A IN2013MU03311A IN 2013MU03311 A IN2013MU03311 A IN 2013MU03311A IN 3311MU2013 A IN3311MU2013 A IN 3311MU2013A IN 2013MU03311 A IN2013MU03311 A IN 2013MU03311A
Authority
IN
India
Prior art keywords
burns
leaving
treatment
active ingredients
scar mark
Prior art date
Application number
Other languages
English (en)
Inventor
Dr Surendra Kumar Gupta
Ankita Gupta
Sakshi Gupta
Original Assignee
Dr Surendra Kumar Gupta
Ankita Gupta
Sakshi Gupta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Surendra Kumar Gupta, Ankita Gupta, Sakshi Gupta filed Critical Dr Surendra Kumar Gupta
Priority to IN3311MU2013 priority Critical patent/IN2013MU03311A/en
Publication of IN2013MU03311A publication Critical patent/IN2013MU03311A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
IN3311MU2013 2013-10-22 2013-10-22 IN2013MU03311A (lt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3311MU2013 IN2013MU03311A (lt) 2013-10-22 2013-10-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3311MU2013 IN2013MU03311A (lt) 2013-10-22 2013-10-22

Publications (1)

Publication Number Publication Date
IN2013MU03311A true IN2013MU03311A (lt) 2015-07-17

Family

ID=54397351

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3311MU2013 IN2013MU03311A (lt) 2013-10-22 2013-10-22

Country Status (1)

Country Link
IN (1) IN2013MU03311A (lt)

Similar Documents

Publication Publication Date Title
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
PH12017500941A1 (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
MX2023008686A (es) Polinucleotidos moduladores.
PH12016501578A1 (en) Pharmaceutical compounds
MD3204025T2 (ro) Compoziții care conțin tulpini bacteriene
MD3206700T2 (ro) Compoziții conținând tulpini bacteriene
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
MY192717A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
SG10201806849WA (en) Cyclopropylamines as lsd1 inhibitors
EA201491505A1 (ru) Соединения для лечения спинальной мышечной атрофии
PH12015500525A1 (en) Formulations of enzalutamide
EA201790273A1 (ru) Флагеллиновые композиции и их применение
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
PH12019502646A1 (en) Pyrazole magl inhibitors
PH12015502161A1 (en) Therapeutic compounds and compositions
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2017004808A (es) Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple.
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
CR20150417A (es) Compuestos de azetidiniloxifenilpirrolidina
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата
GEP20186920B (en) Halogenated quinazolinthf-amines as pde1 inhibitors
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина